Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
J. Clin. Invest. Anne L. Astier, et al. 116:3252 doi:10.1172/JCI29251 [Go to this article.]

Figure 2
CD46 expression in healthy donors and patients with MS. CD46 expression at the cell surface of purified CD4⁺ T cells isolated from healthy donors (Controls), treated patients, or untreated patients was analyzed by flow cytometry using anti-CD46–FITC.